Polyphenols restore endothelial function in DOCA-salt hypertension: Role of endothelin-1 and NADPH oxidase

Free Radical Biology and Medicine

Volumn 43, Issue 3, 2007, Pages 462-473

  Jiménez, Rosario ^a   López Sepúlveda, Rocío ^a   Kadmiri, María ^a   Romero, Miguel ^a   Vera, Rocío ^a   Sánchez, Manuel ^a   Vargas, Félix ^b   O'Valle, Francisco ^b   Zarzuelo, Antonio ^a   Dueñas, Montserrat ^c   Santos Buelga, Celestino ^c   Duarte, Juan ^a  

^a School of Pharmacy UB   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

DOCA salt hypertension; Endothelial dysfunction; Endothelin 1; Free radicals; NADPH oxidase; Red wine polyphenols

Indexed keywords

ACETYLCHOLINE; APOCYNIN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; MALONALDEHYDE; NORADRENALIN; POLYPHENOL; PROSTAGLANDIN F2 ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEINURIA; RAT; RED WINE; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETOPHENONES; ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FLAVONOIDS; GENE EXPRESSION; HYPERTENSION; MALE; NADPH OXIDASE; PHENOLS; PROTEINURIA; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SODIUM CHLORIDE;

ANIMALIA; RATTUS;

EID: 34250869653     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.05.007     Document Type: Article

References (61)

1. St Leger A.S., Cochrane A.L., and Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1 (1979) 1017-1020
2. Renaud S.C., Gueguen R., Schenker J., and d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology 9 (1998) 184-188
3. Wollny T., Aiello L., Di Tommaso D., Bellavia V., Rotilio D., Donati M.B., de Gaetano G., and Iacoviello L. Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production. Br. J. Pharmacol. 127 (1999) 747-755
4. Rimm E.B., Williams P., Fosher K., Criqui M., and Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: metaanalysis of effects on lipids and haemostatic factors. BMJ 319 (1999) 1523-1528
5. Haut M.J., and Cowan D.H. The effect of ethanol on hemostatic properties of human blood platelets. Am. J. Med. 56 (1974) 22-33
6. Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., El Bedoui J., Chataigneau M., and Schini-Kerth V.B. Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 500 (2004) 299-313
7. Perez-Vizcaino F., Duarte J., and Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 40 (2006) 1054-1065
8. Vinson J.A., Teufel K., and Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156 (2001) 67-72
9. Bentzon J.F., Skovenborg E., Hansen C., Moller J., Saint-Cricq de Gaulejac N., Proch J., and Falk E. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation 103 (2001) 1681-1687
10. Auger C., Caporiccio B., Landrault N., Teissedre P.L., Laurent C., Cros G., Besancon P., and Rouanet J.M. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus). J. Nutr. 132 (2002) 1207-1213
11. Waddington E., Puddey I.B., and Croft K.D. Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. Am. J. Clin. Nutr. 79 (2004) 54-61
12. Bernatova I., Pechanova O., Babal P., Kysela S., Stvrtina S., and Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H942-H948
13. Pechanova O., Bernatova I., Babal P., Martinez M.C., Kysela S., Stvrtina S., and Andriantsitohaina R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens. 22 (2004) 1551-1559
14. Sarr M., Chataigneau M., Martins S., Schott C., El Bedoui J., Oak M.H., Muller B., Chataigneau T., and Schini-Kerth V.B. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc. Res. 71 (2006) 794-802
15. Soares de Moura R., Costa Viana F.S., Souza M.A.V., Kovary K., Guedes D.C., Oliviera E.P., Rubenich L.M., Carvalho L.C., Oliveira R.M., Tano T., and Gusmao Correia M.L. Antihypertensive, vasodilator and antioxidant effects of vinifera grape-skin extract. J. Pharm. Pharmacol. 54 (2002) 1515-1520
16. Griendling K.K., and Alexander R.W. Oxidative stress and cardiovascular disease. Circulation 96 (1997) 3264-3265
17. Landmesser U., and Harrison D.G. Oxidant stress as a marker for cardiovascular events: ox marks the spot. Circulation 104 (2001) 2638-2640
18. Oskarsson H.J., and Heistad D.D. Oxidative stress produced by angiotensin too: implications for hypertension and vascular injury. Circulation 95 (1997) 557-559
19. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
20. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14483-14488
21. Somers M.J., Mavromatis K., Galis Z.S., and Harrison D.G. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101 (2000) 1722-1728
22. Wu R., Millette E., Wu L., and de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 19 (2001) 741-748
23. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
24. Gavras H., Brunner H.R., Laragh J.H., Vaughan Jr. E.D., Koss M., Cote L.J., and Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ. Res. 36 (1975) 300-309
25. Schiffrin E.L. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J. Cardiovasc. Pharmacol. 38 (2001) S3-S6
26. Letizia C., Cerci S., De Toma G., D'Ambrosio C., De Ciocchis A., Coassin S., and Scavo D. High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension. J. Hum. Hypertens. 11 (1997) 447-451
27. Elijovich F., Laffer C.L., Amador E., Gavras H., Bresnahan M.R., and Schiffrin E.L. Regulation of plasma endothelin by salt in salt-sensitive hypertension. Circulation 103 (2001) 263-268
28. Lariviere R., Day R., and Schiffrin E.L. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21 (1993) 916-920
29. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., and Chen A.F. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
30. Corder R., Douthwaite J.A., Lees D.M., Khan N.Q., Viseu Dos Santos A.C., Wood E.G., and Carrier M.J. Endothelin-1 synthesis reduced by red wine. Nature 414 (2001) 863-864
31. Khan N.Q., Lees D.M., Douthwaite J.A., Carrier M.J., and Corder R. Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin. Sci. (London) 103 (2002) 72S-75S
32. Galisteo M., Garcia-Saura M.F., Jimenez R., Villar I.C., Wangensteen R., Zarzuelo A., Vargas F., and Duarte J. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats: comparative study with verapamil. Planta Med. 70 (2004) 334-341
33. Duthie G.G., Pedersen M.W., Gardner P.T., Morrice P.C., Jenkinson A.M., McPhail D.B., and Steele G.M. The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur. J. Clin. Nutr. 52 (1998) 733-736
34. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., and Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br. J. Pharmacol. 120 (1997) 1053-1058
35. Duarte J., Andriambeloson E., Diebolt M., and Andriantsitohaina R. Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelial-dependent vasodilatation. Physiol. Res. 53 (2004) 595-602
36. Ghosh M., Wang H.D., and McNeill J.R. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br. J. Pharmacol. 141 (2004) 562-573
37. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
38. Pignatelli P., Ghiselli A., Buchetti B., Carnevale R., Natella F., Germano G., Fimognari F., Di Santo S., Lenti L., and Violi F. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 (2006) 77-83
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
40. Lodi F., Cogolludo A., Duarte J., Moreno L., Coviello A., Peral De Bruno M., Vera R., Galisteo M., Jimenez R., Tamargo J., and Perez-Vizcaino F. Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats. Eur. J. Pharmacol. 544 (2006) 97-103
41. Kitamoto S., Egashira K., Kataoka C., Usui M., Koyanagi M., Takemoto M., and Takeshita A. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J. Hypertens. 18 (2000) 1795-1800
42. Sainz J., Wangensteen R., Rodriguez Gomez I., Moreno J.M., Chamorro V., Osuna A., Bueno P., and Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am. J. Hypertens. 18 (2005) 871-877
43. Kim S., Ohta K., Hamaguchi A., Omura T., Yukimura T., Miura K., Inada Y., Wada T., Ishimura Y., Chatani F., and Iwao H. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24 (1994) 195-204
44. Lacour C., Canals F., Galindo G., Cazaubon C., Segondy D., and Nisato D. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models. Eur. J. Pharmacol. 264 (1994) 307-316
45. Wada T., Kanagawa R., Ishimura Y., Inada Y., and Nishikawa K. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 13 (1995) 113-122
46. de Gracia M.C., Osuna A., O'Valle F., del Moral R.G., Wangensteen R., del Rio C.G., and Vargas F. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J. Am. Soc. Nephrol. 11 (2000) 1995-2000
47. Elmarakby A.A., Loomis E.D., Pollock J.S., and Pollock D.M. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 (2005) 283-287
48. Jin L., Beswick R.A., Yamamoto T., Palmer T., Taylor T.A., Pollock J.S., Pollock D.M., Brands M.W., and Webb R.C. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. J. Physiol. Pharmacol. 57 (2006) 343-357
49. Gonthier M.P., Cheynier V., Donovan J.L., Manach C., Morand C., Mila I., Lapierre C., Remesy C., and Scalbert A. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 133 (2003) 461-467
50. Frohlich E.D., Apstein C., Chobanian A.V., Devereux R.B., Dustan H.P., Dzau V., Fauad-Tarazi F., Horan M.J., Marcus M., Massie B., Pfefer M., Re R., Roccella E., Savage D., and Shub C. The heart in hypertension. N. Engl. J. Med. 327 (1992) 998-1008
51. Wangensteen R., O'Valle F., Del Moral R., Vargas F., and Osuna A. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Med. Sci. Monit. 8 (2002) BR378-BR384
52. Al-Awwadi N.A., Bornet A., Azay J., Araiz C., Delbosc S., Cristol J.P., Linck N., Cros G., and Teissedre P.L. Red wine polyphenols alone or in association with ethanol prevent hypertension, cardiac hypertrophy, and production of reactive oxygen species in the insulin-resistant fructose-fed rat. J. Agric. Food Chem. 52 (2004) 5593-5597
53. Sedeek M.H., Llinas M.T., Drummond H., Fortepiani L., Abram S.R., Alexander B.T., Reckelhoff J.F., and Granger J.P. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42 (2003) 806-810
54. Kahler J., Mendel S., Weckmuller J., Orzechowski H.D., Mittmann C., Koster R., Paul M., Meinertz T., and Munzel T. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J. Mol. Cell. Cardiol. 32 (2000) 1429-1437
55. Ruef J., Moser M., Kubler W., and Bode C. Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc. Pathol. 10 (2001) 311-315
56. Lopez-Ongil S., Saura M., Zaragoza C., Gonzalez-Santiago L., Rodriguez-Puyol M., Lowenstein C.J., and Rodriguez-Puyol D. Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1. Free Radic. Biol. Med. 32 (2002) 406-413
57. Lopez-Ongil S., Senchak V., Saura M., Zaragoza C., Ames M., Ballermann B., Rodriguez-Puyol M., Rodriguez-Puyol D., and Lowenstein C.J. Superoxide regulation of endothelin-converting enzyme. J. Biol. Chem. 275 (2000) 26423-26427
58. Callera G.E., Tostes R.C., Yogi A., Montezano A.C., and Touyz R.M. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin. Sci. (London) 110 (2006) 243-253
59. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol.: Regul. Integr. Comp. Physiol. 285 (2003) R277-R297
60. Laplante M.A., Wu R., Moreau P., and de Champlain J. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic. Biol. Med. 38 (2005) 589-596
61. Leikert J.F., Rathel T.R., Wohlfart P., Cheynier V., Vollmar A.M., and Dirsch V.M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106 (2002) 1614-1617